Active Pharmaceutical Ingredients
- Industrial Coatings
- Dyes and Pigments
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
- Analytical Chemistry
- Cosmetic Ingredient
- Pharmaceutical Intermediates
Ethanone, 1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-, hydrochloride (1:1), also known as CYC206, is a potent and selective inhibitor of the bromodomain and extraterminal domain (BET) proteins.
It is commonly used in the chemical industry as a research chemical, and has been studied for its potential use in a variety of applications, including as a chemical intermediate, in the production of pharmaceuticals, and in the development of new materials.
One of the key properties of CYC206 is its ability to bind to the BET protein family, which includes BRD2, BRD3, BRD4, and other related proteins.
This binding activity has been shown to inhibit the function of these proteins, which are involved in a variety of cellular processes, including transcriptional regulation, DNA repair, and cell cycle progression.
CYC206 has been studied for its potential use in a variety of applications in the chemical industry.
One potential use is as a chemical intermediate, in the production of other chemicals and materials.
For example, it may be used as a building block for the synthesis of other compounds, or as a starting point for the production of new chemicals with specific properties.
Another potential use for CYC206 is in the development of new pharmaceuticals.
The BET protein family has been implicated in a variety of disease processes, including cancer and inflammatory diseases.
As such, compounds like CYC206, which can bind to and inhibit these proteins, have potential as therapeutic agents for the treatment of these diseases.
CYC206 is currently in preclinical development for the treatment of hematological cancers.
CYC206 may also be useful in the development of new materials.
For example, its ability to bind to the BET protein family may make it useful as a scaffold for the design of new materials with specific properties.
This is an area of active research, and there is ongoing work to explore the potential of CYC206 and other compounds like it in the development of new materials with specific properties.
In conclusion, CYC206 is a potent and selective inhibitor of the BET protein family, with a range of potential applications in the chemical industry, including as a chemical intermediate, in the development of new pharmaceuticals, and in the production of new materials.
Its ability to bind to and inhibit the BET protein family makes it an interesting compound for further study and development.